VEGFA and diabetic macular edema: Intravitreal injection of anti-VEGF monoclonal antibody bevacizumab can effectively treat diabetic macular edema and can be used as an adjunctive therapy before advanced PDR surgery, greatly improving the surgical outcome [40,41].